SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
224 hedge funds and large institutions have $7.19B invested in Sage Therapeutics in 2017 Q4 according to their latest regulatory filings, with 79 funds opening new positions, 72 increasing their positions, 63 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
15% more call options, than puts
Call options by funds: $303M | Put options by funds: $264M
14% more repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 63
2.17% more ownership
Funds ownership: 105.18% → 107.36% (+2.2%)
Holders
224
Holding in Top 10
10
Calls
$303M
Puts
$264M
Top Buyers
| 1 | +$271M | |
| 2 | +$102M | |
| 3 | +$95.5M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$86M |
| 5 |
BlackRock
New York
|
+$80.1M |
Top Sellers
| 1 | -$179M | |
| 2 | -$122M | |
| 3 | -$64.3M | |
| 4 |
O
OppenheimerFunds
New York
|
-$51.8M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$37.4M |